Giant Biogene Holding Co., Ltd. (HKG:2367)
Hong Kong
· Delayed Price · Currency is HKD 68.40
+0.65 (0.96%)
Apr 10, 2025, 10:42 AM HKT
Giant Biogene Holding Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Net Income | - | 1,452 | 1,002 | 828.13 | 826.45 | Upgrade
|
Depreciation & Amortization | - | 33.69 | 27.24 | 23.94 | 22.14 | Upgrade
|
Other Amortization | - | 0.48 | 0.39 | 0.27 | 0.15 | Upgrade
|
Loss (Gain) From Sale of Assets | - | 2.88 | 2.91 | 0.18 | 0.23 | Upgrade
|
Loss (Gain) From Sale of Investments | - | -29.33 | 8.28 | -14.47 | -154.78 | Upgrade
|
Stock-Based Compensation | - | 20.52 | 17.66 | 16.49 | 0.59 | Upgrade
|
Provision & Write-off of Bad Debts | - | -0.03 | -0.15 | 0.05 | -2.07 | Upgrade
|
Other Operating Activities | - | 39.65 | 4.94 | -104.34 | 16.02 | Upgrade
|
Change in Accounts Receivable | - | -32.58 | -3.64 | -11.16 | -37.51 | Upgrade
|
Change in Inventory | - | -17.77 | -94.36 | -24.61 | -14.44 | Upgrade
|
Change in Accounts Payable | - | 78.46 | 31.04 | -8.33 | 9.17 | Upgrade
|
Change in Unearned Revenue | - | 24.7 | -3.23 | 13.54 | -3.26 | Upgrade
|
Change in Other Net Operating Assets | - | 75.01 | -61.49 | -27.28 | 171.44 | Upgrade
|
Operating Cash Flow | - | 1,647 | 931.64 | 692.4 | 834.12 | Upgrade
|
Operating Cash Flow Growth | - | 76.83% | 34.55% | -16.99% | 27.07% | Upgrade
|
Capital Expenditures | - | -226.3 | -152.66 | -75 | -75.51 | Upgrade
|
Divestitures | - | 33.13 | - | - | - | Upgrade
|
Sale (Purchase) of Intangibles | - | -2.13 | -0.59 | -0.13 | -0.83 | Upgrade
|
Investment in Securities | - | -379.47 | -718.65 | 1,447 | -686.94 | Upgrade
|
Other Investing Activities | - | 47.49 | 13.16 | 210.72 | 242.16 | Upgrade
|
Investing Cash Flow | - | -527.28 | -858.74 | 1,563 | -521.12 | Upgrade
|
Long-Term Debt Repaid | - | -1.05 | -0.19 | - | - | Upgrade
|
Net Debt Issued (Repaid) | - | -1.05 | -0.19 | - | - | Upgrade
|
Issuance of Common Stock | - | 56.4 | 583.51 | 0.06 | - | Upgrade
|
Repurchase of Common Stock | - | - | -6,236 | - | - | Upgrade
|
Dividends Paid | - | - | -367.46 | -2,550 | - | Upgrade
|
Other Financing Activities | - | -3.54 | -11.67 | -68.62 | -17.52 | Upgrade
|
Financing Cash Flow | - | 51.81 | -5,790 | 4,476 | -17.52 | Upgrade
|
Foreign Exchange Rate Adjustments | - | 1.09 | -55.18 | 3.98 | - | Upgrade
|
Net Cash Flow | - | 1,173 | -5,772 | 6,735 | 295.48 | Upgrade
|
Free Cash Flow | - | 1,421 | 778.97 | 617.4 | 758.62 | Upgrade
|
Free Cash Flow Growth | - | 82.44% | 26.17% | -18.62% | 32.86% | Upgrade
|
Free Cash Flow Margin | - | 40.33% | 32.95% | 39.77% | 63.72% | Upgrade
|
Free Cash Flow Per Share | - | 1.45 | 0.76 | 0.62 | 0.76 | Upgrade
|
Cash Income Tax Paid | - | 205.76 | 172.7 | 218.26 | 121.13 | Upgrade
|
Levered Free Cash Flow | - | 1,057 | -6,104 | 5,352 | 2,305 | Upgrade
|
Unlevered Free Cash Flow | - | 1,057 | -6,104 | 5,352 | 2,305 | Upgrade
|
Change in Net Working Capital | -123.91 | -223.25 | 6,705 | -4,817 | -1,856 | Upgrade
|
Updated Sep 26, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.